🇬🇧 Next Day Delivery in the UK (Order Before 5PM)·🌍 Ships Globally·🔬 Research Purposes Only·✅ COAs Available on Request·🔒 Secure Checkout·⚡ Industry Standard Purity·📦 Discreet Packaging·🇬🇧 Next Day Delivery in the UK (Order Before 5PM)·🌍 Ships Globally·🔬 Research Purposes Only·✅ COAs Available on Request·🔒 Secure Checkout·⚡ Industry Standard Purity·📦 Discreet Packaging·
Zenterex

Research Purposes Only

SS-31

Cellular / Energy

SS-31

C₃₂H₄₉N₉O₅

Key Research Findings

  • First peptide shown to selectively target the inner mitochondrial membrane via cardiolipin interaction.
  • Demonstrated significant reduction in myocardial infarction size in ischaemia-reperfusion animal models.
  • Improves mitochondrial morphology and ATP production in aged tissue models.
  • Currently in clinical trials for heart failure with preserved ejection fraction (HFpEF).

Overview

SS-31 (Elamipretide) is a cell-permeable, mitochondria-targeting tetrapeptide developed by Hazel Szeto and Peter Schiller. It is designed to concentrate selectively in the inner mitochondrial membrane, where it interacts with cardiolipin to stabilise the electron transport chain and reduce oxidative stress.

Mechanism of Action

SS-31 binds to cardiolipin — a phospholipid unique to the inner mitochondrial membrane — stabilising its association with cytochrome c. This preserves electron transport chain efficiency, reduces superoxide generation, and protects mitochondrial cristae architecture during metabolic stress.

Research Effects

Mitochondrial Protection

Extensive Research

Multiple independent studies confirm SS-31 preserves mitochondrial membrane integrity and electron transport chain function during ischaemic and oxidative stress.

Antioxidant

Extensive Research

Reduces mitochondrial ROS generation by stabilising electron flow through the respiratory chain, with consistent findings across cell and animal models.

Cardiac Function

Moderate Research

Animal studies and early clinical data show improvements in cardiac output, reduced fibrosis, and better exercise tolerance in heart failure models.

Neuroprotection

Moderate Research

Research in neurodegenerative models (Parkinson's, Alzheimer's) shows SS-31 reduces neuronal loss linked to mitochondrial dysfunction.

Research Purposes Only — All information on this page is provided for scientific research purposes only. This product is not intended for human consumption, diagnosis, treatment, or prevention of any disease.

Quick Facts

Molecular FormulaC₃₂H₄₉N₉O₅
Molecular Weight639.80 g/mol
CAS Number736992-21-5
SequenceD-Arg-2′,6′-Dmt-Lys-Phe-NH₂
Half-Life~2 hours
SolubilityWater (1 mg/mL)
Storage−20 °C
More in Cellular / Energy

Research Status Key

Extensive Research
Moderate Research
Preliminary Research

Related Peptides

Cart